DK1137407T3 - Fremgangsmåde til fremstilling af en formulering af topisk beta-blokkere med forbedret effektivitet - Google Patents

Fremgangsmåde til fremstilling af en formulering af topisk beta-blokkere med forbedret effektivitet

Info

Publication number
DK1137407T3
DK1137407T3 DK99905124T DK99905124T DK1137407T3 DK 1137407 T3 DK1137407 T3 DK 1137407T3 DK 99905124 T DK99905124 T DK 99905124T DK 99905124 T DK99905124 T DK 99905124T DK 1137407 T3 DK1137407 T3 DK 1137407T3
Authority
DK
Denmark
Prior art keywords
formulation
preparing
improved efficacy
beta blockers
topical beta
Prior art date
Application number
DK99905124T
Other languages
Danish (da)
English (en)
Inventor
Bakulesh Mafatlal Khamar
Original Assignee
Bakulesh Mafatlal Khamar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bakulesh Mafatlal Khamar filed Critical Bakulesh Mafatlal Khamar
Application granted granted Critical
Publication of DK1137407T3 publication Critical patent/DK1137407T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47042-Quinolinones, e.g. carbostyril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355Non-condensed oxazines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99905124T 1998-12-11 1999-03-04 Fremgangsmåde til fremstilling af en formulering af topisk beta-blokkere med forbedret effektivitet DK1137407T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LK1157898 1998-12-11
PCT/IB1999/000378 WO2000035439A1 (en) 1998-12-11 1999-03-04 The process for manufacturing formulation of topical beta blockers with improved efficacy

Publications (1)

Publication Number Publication Date
DK1137407T3 true DK1137407T3 (da) 2004-05-10

Family

ID=19720977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99905124T DK1137407T3 (da) 1998-12-11 1999-03-04 Fremgangsmåde til fremstilling af en formulering af topisk beta-blokkere med forbedret effektivitet

Country Status (10)

Country Link
EP (1) EP1137407B1 (ru)
AP (1) AP2001002206A0 (ru)
AU (1) AU770365B2 (ru)
BR (1) BR9916107A (ru)
CA (1) CA2354765A1 (ru)
DK (1) DK1137407T3 (ru)
EA (1) EA004050B1 (ru)
IL (1) IL143687A0 (ru)
RU (1) RU2218156C2 (ru)
WO (1) WO2000035439A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200902453B (en) * 2006-10-31 2010-07-28 Alcon Res Ltd PAI-1 binding modulators for the treatment of ocular disorders
JP5240586B2 (ja) 2007-01-29 2013-07-17 ブイライフ サイエンス テクノロジーズ ピーブイティー リミテッド 糖尿病性合併症治療用薬学的組成物
EP4126076A1 (en) 2020-03-31 2023-02-08 Sentiss Pharma Private Limited A sterilization process of timolol gel forming solution through aseptic filtration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
JPH0773394B2 (ja) * 1988-03-09 1995-08-02 富士通株式会社 異種通信網の一元的通信網への統合方法
EP0582321A1 (de) * 1992-01-17 1994-02-09 Gramer, Eugen, Prof.Dr.med.Dr.jur. Kombinationspräparat auf der Basis von Dipivalylepinephrin (DPE) und Betablocker zur Augeninnendrucksenkung

Also Published As

Publication number Publication date
BR9916107A (pt) 2002-04-30
AU2541199A (en) 2000-07-03
AP2001002206A0 (en) 2001-09-30
EP1137407B1 (en) 2004-02-18
EA200100655A1 (ru) 2002-04-25
WO2000035439A1 (en) 2000-06-22
AU770365B2 (en) 2004-02-19
EP1137407A1 (en) 2001-10-04
CA2354765A1 (en) 2000-06-22
IL143687A0 (en) 2002-04-21
EA004050B1 (ru) 2003-12-25
RU2218156C2 (ru) 2003-12-10

Similar Documents

Publication Publication Date Title
PT1077957E (pt) Derivados do acido oxi-iminoalcanoico
DK0708114T3 (da) Fremgangsmåde til fremstilling af alkylerede galactomannaner
DK2332915T3 (da) beta2-Adrenoceptoragonister
DK1317181T3 (da) Fremgangsmåde til fremstilling af en herbicid faststofformulering
PT1105382E (pt) Metodo para a preparacao de citalopran
NO20003131D0 (no) Krystallinsk teriparatid
DK1150966T3 (da) Fremgangsmåde til fremstilling af 5-cyanophthalid
DK1140034T3 (da) Formulering af divalproex-natrium med kontrolleret frigivelse
NO20022624L (no) Heterocyklo-alkylsulfonylderivater som anti- inflammatoriske/smertestillende midler
DK1065938T3 (da) Fremgangsmåde til fremstilling af et smøremateriale
NO20020030L (no) Krystallinske 1-metylkarbapenemforbindelser
PT1147075E (pt) Processo para a preparacao de cloridrato de l-fenilefrina
BR9711201A (pt) Processo para a prepara-ao de um composto
DK1272489T3 (da) Fremgangsmåde til præparation af cabergolins krystallinske form I
DK1005444T3 (da) Fremgangsmåde til fremstilling af aromatiske aminer
ID28121A (id) Proses pembuatan sediaan-sediaan optalmik topikal tanpa efek-efek sistematik
ATE277016T1 (de) Beta-alaninderivate
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
NO995851D0 (no) Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse
DK1137407T3 (da) Fremgangsmåde til fremstilling af en formulering af topisk beta-blokkere med forbedret effektivitet
NO20004016L (no) Kosmetisk preparat inneholdende en forbindelse med aktivitetsstimulerende interlevkin-6
PT1200414E (pt) Processo para a preparacao de pirimidnas substituidas
DK1041081T3 (da) Fremgangsmåde til fremstilling af et præparat med höjt gangliosidindhold
DK1308454T3 (da) Fremgangsmåde til fremstilling af platinforbindelse
IS5821A (is) Kristalluð form af ósanetant